From December 2020 through June 2021, according to most recent data, over than 2.4 billion doses of COVID-19 vaccine have been administrated globally (458 million fully vaccinated, that is 5.9% of global population) over the world. Numerous adverse reactions after messenger RNA (mRNA)-based ...
WASHINGTON, Feb. 4 (Xinhua) -- The U.S. Centers for Disease Control and Prevention (CDC) on Friday endorsed recommendation from its vaccine advisers for use of the Moderna COVID-19 vaccine for people ages 18 years and older. The recommendation came after the U.S. Food and Drug Administr...
Prior research has shown that Pfizer's and Johnson & Johnson's vaccines were effective against COVID-19 for at least six months. In this new effort, the researchers sought to find out if the same is true for the Moderna vaccine. To determine the efficacy of the Moderna vaccine over time,...
Such experience in developing customized cancer vaccines served as the basis for the rapid development of a Covid-19 vaccine candidate during the initial stages of the pandemic. It is important to note that Moderna had already been administering mRNA vaccines to patients before it developed a Covi...
(FOX 2) - The Michigan Department of Health and Human Services was notified by medical distribution service McKesson that several shipments of the Moderna vaccine shipped on Sunday, Jan. 17, had their temperature reported as going out of range and getting too cold. McKesson said t...
The FDA is looking to quickly approve Moderna’s coronavirus vaccine after it was unanimously backed by a panel of experts.
In this study of sperm parameters before and after 2 doses of a COVID-19 mRNA vaccine, there were no significant decreases in any sperm parameter among this small cohort of healthy men. Because the vaccines contain mRNA and not the live virus, it is unlikely that the vaccine would affect...
Intriguingly, some studies on retinal vascular occlusion have been related to mRNA COVID-19 vaccination14,15; the vaccines implicated include mRNA vaccines, mRNA-127310 and BNT162b27,11,16, as well as the viral vector-based vaccine ChAdOx16,12,17. However, the quality of these data was ...
While expressing multiple antigens from a single mRNA could potentially solve many of the problems of co-delivery of multiple antigens, a technical solution for our goal of creating such an mRNA vaccine, and one that would also more closely recapitulate an infected cell, remained unclear. In ...
This cohort study examines the incidence of retinal vascular occlusion in individuals after receiving the mRNA COVID-19 vaccine.